D75.A Glucose-6-phosphate dehydrogenase (G6PD) deficiency without anemia

Name of the Condition

• Glucose-6-phosphate dehydrogenase (G6PD) deficiency without anemia

Summary

Glucose-6-phosphate dehydrogenase (G6PD) deficiency without anemia is a hereditary condition characterized by reduced levels of the G6PD enzyme, which is essential for protecting red blood cells from oxidative damage. In the absence of anemia, individuals may not exhibit overt symptoms but remain at risk for hemolysis (red blood cell breakdown) under specific triggers. The condition is inherited in an X-linked recessive pattern, primarily affecting males, though carrier females may experience mild symptoms.

Causes

G6PD deficiency is caused by genetic mutations in the G6PD gene, which impairs the enzyme's ability to function properly. These mutations reduce the enzyme's stability or activity, leaving red blood cells vulnerable to oxidative stress. The condition is inherited and passed down through families, with the gene located on the X chromosome.

Risk Factors

• Male gender (due to X-linked inheritance).
• Family history of G6PD deficiency or related hemolytic disorders.
• Exposure to oxidative stressors, such as certain medications, infections, or foods.
• Geographic or ethnic background, as the condition is more prevalent in regions with historical malaria exposure (e.g., Mediterranean, African, Middle Eastern, and Southeast Asian populations).

Symptoms

• Asymptomatic in most cases, especially when not exposed to triggers.
• Mild jaundice or dark urine (hemoglobinuria) during hemolytic episodes.
• Fatigue or pallor if hemolysis is significant, though anemia is not present.
• Abdominal or back pain in severe hemolytic events.

Diagnosis

Diagnosis involves confirming the absence of anemia while identifying G6PD deficiency. Laboratory tests include a complete blood count (CBC) to rule out anemia and a G6PD activity assay, which measures enzyme levels in red blood cells. Additional tests may include a peripheral blood smear to assess for hemolysis or genetic testing to identify specific mutations. Diagnosis is typically made during screening or after a hemolytic event.

Treatment Options

Treatment focuses on managing hemolytic episodes and avoiding triggers. For acute hemolysis, supportive care includes hydration and discontinuing offending agents. In severe cases, blood transfusions may be necessary. Long-term management involves educating patients on avoiding known triggers, such as certain medications (e.g., sulfonamides, antimalarials) or foods (e.g., fava beans). No specific cure exists, but most individuals lead normal lives with proper precautions.

Prognosis and Follow-Up

The prognosis is generally good for individuals without anemia, as they often remain asymptomatic. However, hemolytic episodes can occur with exposure to triggers, requiring prompt recognition and management. Follow-up involves regular monitoring for signs of hemolysis and education on trigger avoidance. Genetic counseling may be recommended for families to understand inheritance patterns.

Complications

• Acute hemolytic anemia (if triggers are encountered).
• Kidney failure or other organ damage in severe hemolytic events.
• Increased risk of jaundice or gallstones due to chronic hemolysis.
• Potential for severe reactions to oxidative stressors, such as infections or medications.

Lifestyle & Prevention

• Avoid known triggers, including specific medications, foods (e.g., fava beans), and chemicals.
• Use caution with infections, as they can induce hemolysis.
• Wear medical identification (e.g., bracelet) indicating G6PD deficiency.
• Maintain good hydration and overall health to reduce oxidative stress.

When to Seek Professional Help

Seek medical attention if experiencing symptoms of hemolysis, such as dark urine, jaundice, or unexplained fatigue, especially after exposure to potential triggers. Immediate care is necessary for severe reactions, including difficulty breathing, chest pain, or signs of organ dysfunction.

Tips for Medical Coders

When coding for G6PD deficiency without anemia, use ICD-10-CM code D75.A. Documentation should specify the absence of anemia and any associated hemolytic events or triggers. Ensure the code is supported by laboratory results (e.g., G6PD activity assay) and clinical findings. Avoid using this code if anemia is present, as it would require a different code.